000 01454 a2200361 4500
005 20250514070322.0
264 0 _c20030822
008 200308s 0 0 eng d
022 _a1466-4860
024 7 _a10.1038/sj.thj.6200245
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Yuan
245 0 0 _aEffect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells.
_h[electronic resource]
260 _bThe hematology journal : the official journal of the European Haematology Association
_c2003
300 _a187-97 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aDrug Interactions
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFlow Cytometry
650 0 4 _aHL-60 Cells
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aK562 Cells
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aOligodeoxyribonucleotides, Antisense
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xanalysis
700 1 _aLei, Xiao Yong
773 0 _tThe hematology journal : the official journal of the European Haematology Association
_gvol. 4
_gno. 3
_gp. 187-97
856 4 0 _uhttps://doi.org/10.1038/sj.thj.6200245
_zAvailable from publisher's website
999 _c12550934
_d12550934